Search

Displaying results 2281 - 2290 of 7058 in total
  1. Drug

    Bensuldazic acid

    go.drugbank.com/drugs/DB21135
    Experimental

    Bensuldazic acid is a small molecule drug. Bensuldazic acid has a monoisotopic molecular weight of 282.05 Da.

  2. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid is a small molecule drug. Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  3. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid is a small molecule drug. Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  4. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid is a small molecule drug. Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  5. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid is a small molecule drug. Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  6. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil is a small molecule drug. Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  7. Drug

    Capecitabine

    go.drugbank.com/drugs/DB01101
    ApprovedInvestigational

    Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

    Categories: Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic IndexSynonyms: pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate, Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
  8. Drug

    Fenfluramine

    go.drugbank.com/drugs/DB00574
    ApprovedIllicitInvestigationalWithdrawn

    [A214688, A214691, A214700] Fenfluramine was granted initial FDA approval in 1973 prior to its withdrawal; it was granted a new FDA approval on June 25, 2020, for treatment of patients with Dravet syndrome … Dravet syndrome is a pediatric encephalopathy that typically manifests within the first year of life following exposure to elevated temperatures.

    Synonyms: DL-FenfluramineInternational brands: Ponderax PA
  9. Drug

    Tazemetostat

    go.drugbank.com/drugs/DB12887
    ApprovedInvestigational

    [A190363] Tazemetaostat was granted FDA approval on 23 January 2020.[L11476] … Tazemetostat is a methyltransferase inhibitor used to treat metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

  10. Drug

    Clogestone

    go.drugbank.com/drugs/DB19526
    Experimental

    Clogestone is a small molecule drug. Clogestone has a monoisotopic molecular weight of 364.18 Da.